Dogness (International) Corporation Class A Common Stock
DOGZDogness (International) Corporation Class A (DOGZ) specializes in designing and manufacturing pet products, including smart pet devices, feeders, and accessories. Founded with a focus on innovation and quality, the company aims to enhance the daily lives of pets and their owners through technology-driven solutions. Its product range includes smart collars, automatic feeders, and other connected pet care devices.
Company News
Shares of Ascent Solar Technologies, Inc. (NASDAQ: ASTI) fell sharply during Wednesday’s session after the company announced pricing of a $6 million public offering of shares at $0.14 per share. Ascent Solar Technologies shares dipped 50% to $0.1374 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers Marin Soft...
Shares of Agenus Inc. (NASDAQ: AGEN) fell sharply during Monday’s session. Agenus disclosed a 1-for-20 reverse stock split of common stock. Agenus Inc. (NASDAQ: AGEN) declined 17% to $0.4181 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Auddia Inc. (NASDAQ: AUUD) shares jumped 231.7% to $4.72 after the compan...
Shares of Marvell Technology, Inc. (NASDAQ: MRVL) fell sharply during Friday’s session after the company reported fourth-quarter financial results and issued weak Q1 guidance. Marvell said fourth-quarter revenue increased 1% year-over-year to $1.427 billion, which beat the consensus estimate of $1.42 billion. The chip designer reported quarter...
Shares of Freshpet, Inc. (NASDAQ: FRPT) gained 15.5% to $106.29 after the company reported better-than-expected fourth-quarter financial results. Freshpet posted quarterly earnings of 31 cents per share, beating market estimates of 5 cents per share. The company’s quarterly sales came in at $215.42 million versus expectations of $204.36 millio...
Shares of Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) rose sharply during Tuesday’s session after the company released topline data from the PACIFIC Phase 1b/2a study evaluating bexicaserin (LP352) for seizures associated with a broad range of Developmental and Epileptic Encephalopathies (DEEs). Longboard Pharmaceuticals shares jumped 199....
